Pharmacovigilance Market Report

Global Pharmacovigilance Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：148
  • REPORT CODE：GMM830045
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pharmacovigilance market report explains the definition, types, applications, major countries, and major players of the Pharmacovigilance market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Atlantic Research Group

    • GSK

    • Mapi Group

    • Accenture Plc

    • Eli Lilly and Company

    • Chiltern

    • ICON plc

    • PRA Health Sciences Inc

    • Elsevier

    • Clinquest Group BV

    By Type:

    • Chemotherapy

    • Contract Outsourcing

    By End-User:

    • Pharma and Biotech Companies

    • Contract Research Organizations (CROs)

    • Business Process Outsourcing (BPO) Firms

    • Other Pharmacovigilance Service Providers

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pharmacovigilance Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pharmacovigilance Outlook to 2028- Original Forecasts

    • 2.2 Pharmacovigilance Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pharmacovigilance Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pharmacovigilance Market- Recent Developments

    • 6.1 Pharmacovigilance Market News and Developments

    • 6.2 Pharmacovigilance Market Deals Landscape

    7 Pharmacovigilance Raw Materials and Cost Structure Analysis

    • 7.1 Pharmacovigilance Key Raw Materials

    • 7.2 Pharmacovigilance Price Trend of Key Raw Materials

    • 7.3 Pharmacovigilance Key Suppliers of Raw Materials

    • 7.4 Pharmacovigilance Market Concentration Rate of Raw Materials

    • 7.5 Pharmacovigilance Cost Structure Analysis

      • 7.5.1 Pharmacovigilance Raw Materials Analysis

      • 7.5.2 Pharmacovigilance Labor Cost Analysis

      • 7.5.3 Pharmacovigilance Manufacturing Expenses Analysis

    8 Global Pharmacovigilance Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pharmacovigilance Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pharmacovigilance Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pharmacovigilance Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmacovigilance Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Contract Outsourcing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmacovigilance Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharma and Biotech Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Contract Research Organizations (CROs) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Business Process Outsourcing (BPO) Firms Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Pharmacovigilance Service Providers Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pharmacovigilance Market Analysis and Outlook till 2022

    • 10.1 Global Pharmacovigilance Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pharmacovigilance Consumption (2017-2022)

      • 10.2.2 Canada Pharmacovigilance Consumption (2017-2022)

      • 10.2.3 Mexico Pharmacovigilance Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pharmacovigilance Consumption (2017-2022)

      • 10.3.2 UK Pharmacovigilance Consumption (2017-2022)

      • 10.3.3 Spain Pharmacovigilance Consumption (2017-2022)

      • 10.3.4 Belgium Pharmacovigilance Consumption (2017-2022)

      • 10.3.5 France Pharmacovigilance Consumption (2017-2022)

      • 10.3.6 Italy Pharmacovigilance Consumption (2017-2022)

      • 10.3.7 Denmark Pharmacovigilance Consumption (2017-2022)

      • 10.3.8 Finland Pharmacovigilance Consumption (2017-2022)

      • 10.3.9 Norway Pharmacovigilance Consumption (2017-2022)

      • 10.3.10 Sweden Pharmacovigilance Consumption (2017-2022)

      • 10.3.11 Poland Pharmacovigilance Consumption (2017-2022)

      • 10.3.12 Russia Pharmacovigilance Consumption (2017-2022)

      • 10.3.13 Turkey Pharmacovigilance Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pharmacovigilance Consumption (2017-2022)

      • 10.4.2 Japan Pharmacovigilance Consumption (2017-2022)

      • 10.4.3 India Pharmacovigilance Consumption (2017-2022)

      • 10.4.4 South Korea Pharmacovigilance Consumption (2017-2022)

      • 10.4.5 Pakistan Pharmacovigilance Consumption (2017-2022)

      • 10.4.6 Bangladesh Pharmacovigilance Consumption (2017-2022)

      • 10.4.7 Indonesia Pharmacovigilance Consumption (2017-2022)

      • 10.4.8 Thailand Pharmacovigilance Consumption (2017-2022)

      • 10.4.9 Singapore Pharmacovigilance Consumption (2017-2022)

      • 10.4.10 Malaysia Pharmacovigilance Consumption (2017-2022)

      • 10.4.11 Philippines Pharmacovigilance Consumption (2017-2022)

      • 10.4.12 Vietnam Pharmacovigilance Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pharmacovigilance Consumption (2017-2022)

      • 10.5.2 Colombia Pharmacovigilance Consumption (2017-2022)

      • 10.5.3 Chile Pharmacovigilance Consumption (2017-2022)

      • 10.5.4 Argentina Pharmacovigilance Consumption (2017-2022)

      • 10.5.5 Venezuela Pharmacovigilance Consumption (2017-2022)

      • 10.5.6 Peru Pharmacovigilance Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pharmacovigilance Consumption (2017-2022)

      • 10.5.8 Ecuador Pharmacovigilance Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pharmacovigilance Consumption (2017-2022)

      • 10.6.2 Kuwait Pharmacovigilance Consumption (2017-2022)

      • 10.6.3 Oman Pharmacovigilance Consumption (2017-2022)

      • 10.6.4 Qatar Pharmacovigilance Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pharmacovigilance Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pharmacovigilance Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pharmacovigilance Consumption (2017-2022)

      • 10.7.2 South Africa Pharmacovigilance Consumption (2017-2022)

      • 10.7.3 Egypt Pharmacovigilance Consumption (2017-2022)

      • 10.7.4 Algeria Pharmacovigilance Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pharmacovigilance Consumption (2017-2022)

      • 10.8.2 New Zealand Pharmacovigilance Consumption (2017-2022)

    11 Global Pharmacovigilance Competitive Analysis

    • 11.1 Atlantic Research Group

      • 11.1.1 Atlantic Research Group Company Details

      • 11.1.2 Atlantic Research Group Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Atlantic Research Group Pharmacovigilance Main Business and Markets Served

      • 11.1.4 Atlantic Research Group Pharmacovigilance Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Pharmacovigilance Main Business and Markets Served

      • 11.2.4 GSK Pharmacovigilance Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Mapi Group

      • 11.3.1 Mapi Group Company Details

      • 11.3.2 Mapi Group Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Mapi Group Pharmacovigilance Main Business and Markets Served

      • 11.3.4 Mapi Group Pharmacovigilance Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Accenture Plc

      • 11.4.1 Accenture Plc Company Details

      • 11.4.2 Accenture Plc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Accenture Plc Pharmacovigilance Main Business and Markets Served

      • 11.4.4 Accenture Plc Pharmacovigilance Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Eli Lilly and Company

      • 11.5.1 Eli Lilly and Company Company Details

      • 11.5.2 Eli Lilly and Company Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Eli Lilly and Company Pharmacovigilance Main Business and Markets Served

      • 11.5.4 Eli Lilly and Company Pharmacovigilance Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Chiltern

      • 11.6.1 Chiltern Company Details

      • 11.6.2 Chiltern Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Chiltern Pharmacovigilance Main Business and Markets Served

      • 11.6.4 Chiltern Pharmacovigilance Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 ICON plc

      • 11.7.1 ICON plc Company Details

      • 11.7.2 ICON plc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 ICON plc Pharmacovigilance Main Business and Markets Served

      • 11.7.4 ICON plc Pharmacovigilance Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 PRA Health Sciences Inc

      • 11.8.1 PRA Health Sciences Inc Company Details

      • 11.8.2 PRA Health Sciences Inc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 PRA Health Sciences Inc Pharmacovigilance Main Business and Markets Served

      • 11.8.4 PRA Health Sciences Inc Pharmacovigilance Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Elsevier

      • 11.9.1 Elsevier Company Details

      • 11.9.2 Elsevier Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Elsevier Pharmacovigilance Main Business and Markets Served

      • 11.9.4 Elsevier Pharmacovigilance Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Clinquest Group BV

      • 11.10.1 Clinquest Group BV Company Details

      • 11.10.2 Clinquest Group BV Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Clinquest Group BV Pharmacovigilance Main Business and Markets Served

      • 11.10.4 Clinquest Group BV Pharmacovigilance Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Pharmacovigilance Market Outlook by Types and Applications to 2028

    • 12.1 Global Pharmacovigilance Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Contract Outsourcing Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pharmacovigilance Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharma and Biotech Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Contract Research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Business Process Outsourcing (BPO) Firms Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Pharmacovigilance Service Providers Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pharmacovigilance Market Analysis and Outlook to 2028

    • 13.1 Global Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.2 UK Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.5 France Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.3 India Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pharmacovigilance Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pharmacovigilance Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pharmacovigilance Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pharmacovigilance

    • Figure of Pharmacovigilance Picture

    • Table Global Pharmacovigilance Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pharmacovigilance Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Outsourcing Consumption and Growth Rate (2017-2022)

    • Figure Global Pharma and Biotech Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Contract Research Organizations (CROs) Consumption and Growth Rate (2017-2022)

    • Figure Global Business Process Outsourcing (BPO) Firms Consumption and Growth Rate (2017-2022)

    • Figure Global Other Pharmacovigilance Service Providers Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacovigilance Consumption by Country (2017-2022)

    • Table North America Pharmacovigilance Consumption by Country (2017-2022)

    • Figure United States Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Canada Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmacovigilance Consumption by Country (2017-2022)

    • Figure Germany Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure UK Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Spain Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure France Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Italy Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Finland Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Norway Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Poland Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Russia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table APAC Pharmacovigilance Consumption by Country (2017-2022)

    • Figure China Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure India Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table South America Pharmacovigilance Consumption by Country (2017-2022)

    • Figure Brazil Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Chile Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Peru Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table GCC Pharmacovigilance Consumption by Country (2017-2022)

    • Figure Bahrain Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Oman Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table Africa Pharmacovigilance Consumption by Country (2017-2022)

    • Figure Nigeria Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table Oceania Pharmacovigilance Consumption by Country (2017-2022)

    • Figure Australia Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pharmacovigilance Consumption and Growth Rate (2017-2022)

    • Table Atlantic Research Group Company Details

    • Table Atlantic Research Group Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atlantic Research Group Pharmacovigilance Main Business and Markets Served

    • Table Atlantic Research Group Pharmacovigilance Product Portfolio

    • Table GSK Company Details

    • Table GSK Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Pharmacovigilance Main Business and Markets Served

    • Table GSK Pharmacovigilance Product Portfolio

    • Table Mapi Group Company Details

    • Table Mapi Group Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mapi Group Pharmacovigilance Main Business and Markets Served

    • Table Mapi Group Pharmacovigilance Product Portfolio

    • Table Accenture Plc Company Details

    • Table Accenture Plc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accenture Plc Pharmacovigilance Main Business and Markets Served

    • Table Accenture Plc Pharmacovigilance Product Portfolio

    • Table Eli Lilly and Company Company Details

    • Table Eli Lilly and Company Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Pharmacovigilance Main Business and Markets Served

    • Table Eli Lilly and Company Pharmacovigilance Product Portfolio

    • Table Chiltern Company Details

    • Table Chiltern Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiltern Pharmacovigilance Main Business and Markets Served

    • Table Chiltern Pharmacovigilance Product Portfolio

    • Table ICON plc Company Details

    • Table ICON plc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICON plc Pharmacovigilance Main Business and Markets Served

    • Table ICON plc Pharmacovigilance Product Portfolio

    • Table PRA Health Sciences Inc Company Details

    • Table PRA Health Sciences Inc Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table PRA Health Sciences Inc Pharmacovigilance Main Business and Markets Served

    • Table PRA Health Sciences Inc Pharmacovigilance Product Portfolio

    • Table Elsevier Company Details

    • Table Elsevier Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elsevier Pharmacovigilance Main Business and Markets Served

    • Table Elsevier Pharmacovigilance Product Portfolio

    • Table Clinquest Group BV Company Details

    • Table Clinquest Group BV Pharmacovigilance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Clinquest Group BV Pharmacovigilance Main Business and Markets Served

    • Table Clinquest Group BV Pharmacovigilance Product Portfolio

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Outsourcing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharma and Biotech Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract Research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Business Process Outsourcing (BPO) Firms Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Pharmacovigilance Service Providers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Table North America Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure Germany Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure China Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pharmacovigilance Consumption Forecast by Country (2022-2028)

    • Figure Australia Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pharmacovigilance Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US